ABT-888 plus bendamustine is safe and has shown preliminary efficacy in patients with lymphoma Meeting Abstract

  

Authors:	Gerecitano, J. F.; Schwartz, G. K.; Carvajal, R.; Fury, M.; Konner, J.; Hyman, D. M.; Gounder, M.; Gajria, D.; Teitcher, J.; Zhang, Z.; Moskowitz, C. H.; Beumer, J. H.; Chen, A.; Little, R. F.; France, F.; Whang, J.; Winkelman, J.; Stasi, M.; Russell, C.; Cazeau, N.; Kargus, K.; Zelenetz, A. D.
Abstract Title:	ABT-888 plus bendamustine is safe and has shown preliminary efficacy in patients with lymphoma
Meeting Title:	55th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	122
Issue:	21
Meeting Dates:	2013 Dec 7-10
Meeting Location:	New Orleans, LA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2013-11-15
Language:	English
ACCESSION:	WOS:000435860200024
PROVIDER:	wos
Notes:	Meeting Abstract: 4366 -- Source: Wos